Pandorum Technologies Private Limited

Designs and produces 3D human tissues for medical research and therapeutics.

2011 | Bangaluru, Karnataka (India) | Active
Last Updated: December 13, 2024

Pandorum Technologies Profile

Key Indicators

  • Authorised Capital ₹ 4.72 Cr
  • Paid Up Capital ₹ 4.65 Cr
  • Company Age 13 Year, 9 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth 301.44%
  • Profit Growth 19.88%
  • Ebitda 13.84%
  • Net Worth 170.79%
  • Total Assets 160.82%

About Pandorum Technologies

Pandorum Technologies Private Limited (PTPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 May 2011 and has a history of 13 years and nine months. Its registered office is in Bangaluru, Karnataka, India.

The Company is engaged in the Healthcare Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.72 Cr and a paid-up capital of Rs 4.65 Cr, as per Ministry of Corporate Affairs (MCA) records.

Sailesh Tulshan, Sonal Asthana, Tuhin Bhowmick, and Three other members serve as directors at the Company.

Company Details

  • Location

    Bangaluru, Karnataka, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    pandorum.com

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U72200KA2011PTC058650

  • Company No.

    058650

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    16 May 2011

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Bangalore

Industry

Healthcare

Who are the key members and board of directors at Pandorum Technologies?

Board Members (6)

NameDesignationAppointment DateStatus
Tuhin Bhowmick Country flag representing In Director 16-May-2011Current
Sudipta Gautam Country flag representing Us Nominee Director 18-Dec-2019Current
Sonal Asthana Country flag representing In Director 14-Nov-2016Current
Sailesh Tulshan Country flag representing In Director 10-Aug-2018Current
Arun Raja Country flag representing In Director 16-May-2011Current
Manish Belmannu Country flag representing In Nominee Director 18-Jul-2018Current

Financial Performance of Pandorum Technologies.

Pandorum Technologies Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 301.44% increase. The company also saw a substantial improvement in profitability, with a 19.88% increase in profit. The company's net worth Soared by an impressive increase of 170.79%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
301.44%
Revenue from Operations
Total Assets
160.82%
Profit or Loss
19.88%
Net Worth
170.79%
EBITDA
13.84%

What is the Ownership and Shareholding Structure of Pandorum Technologies?

In 2024, Pandorum Technologies had a promoter holding of 84.86% and a public holding of 15.15%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Pandorum Technologies?

Pandorum Technologies has a workforce of 27 employees as of Dec 13, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Pandorum Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pandorum Technologies's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Pandorum Technologies

Recent activity within the organization

  • Annual General Meeting

    Pandorum Technologies Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

    30 Sep 2024

  • Balance Sheet

    Pandorum Technologies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore.

    31 Mar 2024

  • Director Appointment

    Sudipta Gautam was appointed as a Nominee Director was appointed as a Nominee Director on 18 Dec 2019 & has been associated with this company since 5 years 2 months .

    18 Dec 2019

  • Director Appointment

    Sailesh Tulshan was appointed as a Director was appointed as a Director on 10 Aug 2018 & has been associated with this company since 6 years 6 months .

    10 Aug 2018

  • Director Appointment

    Manish Kumar Belmannu was appointed as a Nominee Director was appointed as a Nominee Director on 18 Jul 2018 & has been associated with this company since 6 years 7 months .

    18 Jul 2018

  • Director Appointment

    Sonal Asthana was appointed as a Director was appointed as a Director on 14 Nov 2016 & has been associated with this company since 8 years 3 months .

    14 Nov 2016

Recent News, Updates & Announcement

  • News icon
  • News icon
    Pandorum Technologies secures USD 11 million investment to advance its regenerative therapy for corneal....

    PRNewswireBengaluru (Karnataka) [India], March 15: Pandorum Technologies, a leading biotechnology company, announced today the successful closure of a pre-Series B funding round, securing USD 11 million (INR 88 crore) in investment. The funding was sourced from Mr. Ashish Kacholia, Everest Finance Investment, Acebright Pharma and Ms. Bandana Kankani's syndicate along with existing investors Mr. Sunil Kant Munjal and the Indian Angel Network.Founded by Arun Chandru & Dr. Tuhin Bhowmick, the startup company focuses on Tissue Engineering and Regenerative Medicine. With the current round of funding, Pandorum aims to progress towards the First-in-Human study of its Flagship product Kuragenx- the 'Liquid Cornea', to treat corneal blindness. The funding will also allow the company to advance its tunable technology platform that has demonstrated regenerative potential beyond cornea, such as, for liver, lung and neuronal tissues."We are thrilled to have the support of the notable investors, including Mr. Ashish Kacholia- as we continue to innovate and develop therapeutics to restore healthy tissue functions, in order to help the patients suffering from unmet clinical needs. Our flagship product Kuragenx combines proprietary biomaterials with regenerative nanotherapy, guiding the formation of a functional corneal tissue to restore vision. This is a First-in-Class approach that can truly blur the line between treatment and cure" said Dr. Tuhin Bhowmick, Co-Founder & CEO of Pandorum Technologies.Mr. Ashish Kacholia said, "This startup is working on cure for corneal blindness. Though the journey to commercialization is long, amazing payoffs possible for all mankind. Indian science and scientific community making amazing strides.""There's a paradigm shift happening in the Indian biotech and lifescience sector with deep-tech companies like Pandorum pushing boundaries and creating global innovations. My best wishes to the team for what they have set out to accomplish," said Ms. Bandana Kankani from Nexxtmile who invested and also advised on this funding round."It is inspiring to see a company originating from India started by two young founders poised to change the landscape of cornea transplant and blindness in the world. We are glad to support the team as they navigate the path towards commercializing their cornea regeneration platform, Kuragenx," said Mr. Ashish Sheth - Partner at Orbit Financial Capital (OFC). OFC acted as buyside advisor to Acebright Pharma.Corneal opacity is one of the major causes of blindness worldwide, with millions waiting for donor tissues against significant odds. Pandorum's Kuragenx promotes scarless regeneration of cornea tissue to restore vision, as demonstrated in extensive pre-clinical studies. In 2023, Kuragenx was awarded the Orphan Drug Designation by the USFDA, for the treatment of Neurotrophic Keratitis, a form of ulcerative corneal blindness that is currently untreatable or extremely difficult to treat. Pandorum is currently engaged in clinical manufacturing process and IND enabling studies of Kuragenx, with the aim towards the first patient dosing in 2025, after obtaining due regulatory approvals."Giving back vision with something made in the lab, without depending on donor corneas, is truly transformative. Kudos to our team at Pandorum. Could not have been possible without the support of our investors, partners and the Government enabled R&D ecosystem. Indeed, it's a multi-billion dollar global opportunity; more so, this will positively impact millions of lives," said Arun Chandru, Co-Founder & Director of the company.Pandorum has its R&D labs in Bangalore, India and in the Bay Area, San Francisco, USA, and works with prominent global partners. The company has received competitive grants from the Department of Biotechnology, Government of India, and has previously raised funds from marquee investors and VCs including Sunil Kant Munjal, Binny Bansal, T K Kurien, Sachin Bansal, 021 Capital, Indian Angel Network (IAN) Fund, Karnataka Venture Fund (KITVEN), Kotak Investment Advisors and 500 Startups.For more information, visit www.pandorum.comLogo: https://mma.prnewswire.com/media/2362884/Pandorum_Logo.jpg(ADVERTORIAL DISCLAIMER: The above press release has been provided by PRNewswire.will not be responsible in any way for the content of the same)Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor.

    15 Mar 2024 Lokmat News

  • News icon
  • News icon
  • News icon
  • News icon
    Indian Biotech Startups Defy Odds: Bugworks and Pandorum Win ET Startup Awards for Global Impact and Revolutionary Breakthroughs.

    India's biotech startups making global impact despite challenges. Bugworks beats superbugs with new antibiotics, Pandorum 3D-prints human tissues for medical research. Both win ET Startup Awards. Bugworks CEO humbled, says last antibiotic breakthrough in 1984. Pandorum aims to make personalized organs. Both funded by BIRAC. Biocon's Kiran Mazumdar-Shaw impressed. Tough for biotech to scale up, but grateful for Indian ecosystem..

    24 Jul 2017 Economic Times

Frequently asked questions

  • Pandorum Technologies Private Limited was incorporated on 16 May 2011.

  • The authorized share capital of Pandorum Technologies Private Limited is ₹ 4.72 Cr and paid-up capital is ₹ 4.65 Cr.

  • Currently 6 directors are associated with Pandorum Technologies Private Limited.

    • Sailesh Tulshan
    • Sonal Asthana
    • Tuhin Bhowmick
    • Arun Chandru Raja
    • Sudipta Gautam
    • Manish Kumar Belmannu
  • As per Ministry of Corporate Affairs (Mca), the registered address of Pandorum Technologies Private Limited is Egf 4 5 Bangalore Bioinnovation Centre Helix Biotech Park Electronic City Phas E 1, India, Bengaluru, Karnataka, 560100.

  • The corporate identification number (CIN) of Pandorum Technologies Private Limited is U72200KA2011PTC058650 and the company number is 058650 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Pandorum Technologies Private Limited is https://www.pandorum.com

  • According to the financial reports for the fiscal year 2024, the revenue trend for Pandorum Technologies Private Limited has risen by 301.44%.

  • As Per 2024 financial reports, 27 employees are currently employed by Pandorum Technologies Private Limited.

  • The financial reports for the fiscal year 2024 indicates that The net worth of Pandorum Technologies Private Limited has experienced an upsurge of 170.79%.

  • The most recent Balance Sheet for Pandorum Technologies Private Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on HealthTech & Medical Tech Solutions